Septic shock induced by microbial products and indomethacin

Drug Development Research

Volumn 55, Issue 3, 2002, Pages 139-148

  Moriya, Keisuke ^a   Ohno, Naohito ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Yadomae, Toshiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

glucan; Indomethacin; Lethal toxicity; LPS; NSAIDs; Side effect

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BETA GLUCAN; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LEUKOCYTE; LIVER; MALE; MOUSE; NONHUMAN; SEPTIC SHOCK; SURVIVAL; TOXICITY;

EID: 0036276437     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10046     Document Type: Article

References (44)

1. The mechanisms of action of nonsteroidal antiinflammatory drugs
2. Change of biological activities of (1→3)-β-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment
3. Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury
4. Activation of limulus coagulation factor G by several (1→3)-β-D-glucans: Comparison of the potency of glucans with identical degree of polymerization but different conformations
5. Evidence for tumor necrosis factor a as mediator of toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis
6. Recent progress in immunopharmacology and therapeutic effects of polysaccharides
7. Lentinan as a host defense potentiator (HDP)
8. The role of glucan in the prevention and modification of microparasitic diseases
9. Modification of diverse experimental immunosuppressive states by glucan
10. Schizophyllan
11. Biological characteristic of schizophyllan (SPG) and its clinical effects
12. Cancer cell progression and chemoimmunotherapy: Dual effects in the induction of resistance to therapy
13. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin
14. Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation
15. Nitric oxide synthesis in murine peritoneal macrophages by fungal β-glucans
16. The problems and pitfalls of NSAID therapy in the elderly (Part I)
17. Prostaglandins as endogenous mediators of interleukin 1 production
18. Non-steroidal anti-inflammatory drugs: How do they damage the gut?
19. Lentinan potentiates immunity and prolongs the survival time of some patients
20. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice
21. Antigen-specific response of murine immune system toward a yeast beta-glucan preparation, zymosan
22. Prostaglandin E(1) protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice
23. TNF-alpha but not IL-1alpha is correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury
24. Non-steroidal anti-inflammatory drugs: Uses and complications
25. Structure and antitumor activity of a beta-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395
26. Structure-activity relationship of immunomodulating (1→3)-β-D-glucans
27. Solubilization of yeast cell-wall beta-(1→3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction
28. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity
29. Indomethacin potentiates endotoxin-induced blood flow reduction and histological injury in rat gastric mucosa
30. Relationship between conformation and biological response for (1→3)-β-D-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant
31. Yeast glucan and immunotherapy of infectious diseases
32. Lentinan
33. Association of immunological disorders in lethal side effect of NSAIDs on β-glucan-administered mice
34. Increases in hematopoietic responses cause by β-glucans in mice
35. Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: Up-regulation of TNF, IFN-γ and IL-2, in contrast to down-regulation of IL-6 production
36. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp.
37. Possible action of through inhibition of synthesis of prostaglandins
38. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae
39. Historical overview of non-steroidal anti-inflammatory drugs
40. Immunopharmacological activity of β-glucan: Structure-activity relationship in relation to various conformations
41. Structure-activity relationship of immunomodulating (1→3)-β-D-glucans
42. Simultaneous activation of granulocytes and extrathymic T cells in number and function by excessive administration of nonsteroidal anti-inflammatory drugs
43. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment
44. Conformation-dependent change in antitumor activity of liner and branched (1→3)-β-D-glucans on the basis of conformational elucidation by carbon-13 nuclear magnetic resonance spectroscopy